InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: skitahoe post# 452834

Sunday, 03/20/2022 10:36:37 PM

Sunday, March 20, 2022 10:36:37 PM

Post# of 693057
Of course. Overall Survival is the point of cancer treatments. Everything else including progression free survival is a short cut and not appropriate for a trial with a long fat tale of survivors. NWBO DcVax-L data should be extraordinary.
New SOC that is why there is so much FUD in opposition. Who's OX is eviscerated?
Good news is we can buy more stock at 10% of real intrinsic value. Right now!
At $3.50 - $5.00 it is a good buy that is where Institution will buy in putting a floor on the stock and where many retail will sell. Let you winners run! But at $0.75 it is an incredible buy.
NWBO is the 25x opportunity of 2022-2024.
Néed I remind everyone of Arrowhead and Anavex which 25x increased in 18 month's?
Relax the Linda's got this.
Not investment advice. But personally I think it is the best risk/reward in the market in years.
It will not take a lot of stock to make one comfortable. A large holding might make one a philanthropist. These are the aspirations of many NWBO investors.
Linda Powers got this. Stand by for windfall and let the company do the heavy lifting.
Up to you.
Northwest Bio. Shock & Awe.
50x in 24-36 months. No need for buy out but patience is critical.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News